|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:763-765
© 2004 The American Association for Thoracic Surgery
Brief communication |
a Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo, USA
Received for publication March 15, 2004; accepted for publication March 30, 2004.
* Address for reprints: Jennifer S. Lawton, MD, Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Queeny Tower, Suite 3108, One Barnes-Jewish Hospital Plaza, St Louis, MO 63110, USA
lawtonj{at}msnotes.wustl.edu
Primary sarcoma of the pulmonary artery (PA) is rare. The diagnosis is difficult and often delayed. Two patients with primary sarcoma of the PA that mimicked pulmonary thromboembolic diseases who presented with complications requiring surgical intervention are described. The diagnostic and management issues regarding these often unsuspected but aggressive tumors are discussed.
Clinical summary
PATIENT 1. A 54-year-old woman was admitted for pulmonary thromboendarterectomy workup. She had a past medical history of pulmonary embolism (PE) that occurred 3 months before admission. This was complicated by an area of right lower lobe infarction seen on chest computed tomography (CT) scanning. A deep vein thrombosis of her right femoral vein was diagnosed on lower extremity Doppler investigation as the cause of her PE. Her treatment consisted of anticoagulation and placement of an inferior vena cava filter. The results of all screening tests for a hypercoagulable state were negative. She had progressive shortness of breath over the following 3-month period and was in New York Heart Association class IV at the time of admission. A chest CT scan revealed a massive pulmonary embolus in the right PA (Figure 1, A... A pulmonary arteriogram demonstrated total occlusion of the right PA approximately 4 cm from its origin, whereas the left PA and its branch vessels were normal (Figure 1, B... Echocardiography revealed severe tricuspid regurgitation and a PA systolic pressure of 65 mm Hg. In view of her symptoms and occluded right PA, she underwent a right pulmonary endarterectomy to restore antegrade right pulmonary blood flow. Intraoperatively, extensive clots within the right PA were found and removed. The right PA had a very thickened intima consisting of tan-yellow membranous tissue and nodules that had markedly narrowed the PA lumen. A right PA endarterectomy was performed during hypothermic circulatory arrest. Her postoperative recovery was uneventful, and she was discharged 9 days later. Histopathology revealed a poorly differentiated primary sarcoma arising from the wall of the PA. Immunohistochemical staining revealed that the tumor cells were strongly positive for
-smooth muscle actin and vimentin while negative for creatine kinase and S-100. CD31 stains highlighted the presence of capillaries within the tumor. These results were consistent with a primary leiomyosarcoma of the PA. She was treated with postoperative adjuvant radiation and a chemotherapy regimen consisting of doxorubicin, ifosfamide, mesna, and dacarbazine. Mediastinal lymph node and bony metastatic disease were detected at 5-month follow-up, and she died 7 months later.
|
|
The clinical features of primary sarcoma of the PA can be indistinguishable from those of pulmonary thromboembolic disease, as seen in both described cases. Diagnosis is seldom made preoperatively and is often unsuspected before surgical intervention for acute or chronic pulmonary obstruction.1 An associated past history of deep vein thrombosis, as seen in patient 1, would further mislead the diagnosis to that of chronic pulmonary thromboembolic disease as the cause of the pulmonary vascular obstruction. Atypical cases of PE, such as complete unilateral obstruction of a main PA (patient 1) or recurrent pulmonary emboli despite adequate anticoagulation without evidence of deep vein thrombosis (patient 2), should raise a high index of suspicion for PA sarcoma.2 The radiologic diagnosis of primary PA sarcoma can still be difficult despite technological advances because it is often not possible to distinguish it from acute or chronic PE. Preoperative pulmonary angiography can show intraluminal narrowing of the PAs but is unable to distinguish between tumor and thromboembolic diseases unless atypical features such as pedunculated or lobulated lesions are seen.2 CT scans in both the described patients did not demonstrate any evidence suggestive of PA malignancy. This is not unusual because CT scans cannot differentiate between thrombus and intraluminal tumor unless there is evidence of local invasion or metastatic disease. Gadolinium-diethyl-enetriamine pentaacetic acidenhanced magnetic resonance imaging has been advocated as a useful diagnostic tool demonstrating heterogenous enhancement of a vascularized tumor.3 However, magnetic resonance imaging is not performed during the routine investigative workup for pulmonary thromboembolic disease in most centers. In earlier reports, the diagnosis of primary sarcomas of the PA was often made at postmortem examinations.1 With increased surgical intervention for acute and chronic pulmonary obstructive disease in the modern era, the diagnosis is now often made on the basis of histopathologic analysis of the specimens removed during surgical intervention, as in both the described cases.2
The prognosis of primary sarcoma of the PA is very poor without treatment. There is a mean survival of only 1.5 months after diagnosis, and death is usually due to pulmonary dysfunction and right heart failure.1 Surgical intervention remains the primary treatment. Surgical intervention in the form of pulmonary endarterectomy, resection, and reconstruction of the PA or pneumonectomy have provided significant palliation of symptoms and improved survival.2,4 A median survival of 10 months had been reported after such surgical intervention, as well as significant palliation in terms of improvement in quality of life, exercise tolerance, and hemodynamics.1,2 Despite aggressive surgical treatment, prolonged tumor-free survival or cure is still rare, with only a few reported cases, while most patients die from recurrent and metastatic diseases.2 Treatment of locally advanced PA sarcoma with a combined heart-lung resection followed by heart-lung transplantation has also been attempted.5 The utility of such aggressive treatment is limited by the development of metastatic disease and poor survival outcome.5 There is little information in the published literature regarding the effectiveness of adjuvant therapy for these aggressive tumors. The role of adjuvant radiation therapy is not well defined but is generally advocated because it might decrease the incidence of recurrent tumor. Primary PA sarcoma has a predilection to result in metastatic disease because of its tendency to embolize into the pulmonary arterial tree. Chemotherapy might be effective against microscopic metastatic disease and might decrease the burden of recurrent pulmonary and other systemic disease; however, there has been limited experience with this in the past.
In summary, we present 2 cases of primary PA sarcoma that mimicked pulmonary thromboembolic disease. In both patients the diagnosis of PA sarcoma was made only after pathology was reviewed postoperatively. Despite diagnostic, operative, and oncologic advances over the last few decades, PA sarcoma still remains a diagnostic dilemma associated with a dismal prognosis.
References
This article has been cited by other articles:
![]() |
C. Fernandez-Golfin, P. Escribano, J. Cortina, R. Tello, F. Hernandez, F. Lopez-Rios, J. Delgado Jimenez, and C. Saenz de la Calzada Management of Primary Pulmonary Artery Sarcoma: Experience of a Single Center Angiology, October 1, 2008; 59(5): 636 - 639. [Abstract] [PDF] |
||||
![]() |
H. K. Kim, Y. S. Choi, K. Kim, Y. M. Shim, K. Sung, Y. T. Lee, P. W. Park, and J. Kim Surgical treatment for pulmonary artery sarcoma Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 712 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakahira, H. Ogino, H. Sasaki, and N. Katakami Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 388 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Athanassiadi, C. Grothusen, M. Mengel, and A. Haverich Primary leiomyosarcoma of the pulmonary artery: Is aggressive treatment justified for a long survival? J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 435 - 436. [Full Text] [PDF] |
||||
![]() |
S.-C. Huang, M.-L. Lee, S.-J. Chen, M.-Z. Wu, and C.-I. Chang Pulmonary artery myxoma as a rare cause of dyspnea for a young female patient J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1179 - 1180. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |